{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:55:06Z","timestamp":1793382906911,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"am","delay-in-days":327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.neubiorev.2018.12.005","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T13:03:27Z","timestamp":1544015007000},"page":"49-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":294,"special_numbering":"C","title":["Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment"],"prefix":"10.1016","volume":"106","author":[{"given":"Sandra D.","family":"Comer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neubiorev.2018.12.005_bib0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0893-133X(99)00133-5","article-title":"Persistent increase in the motivation to take heroin in rats with a history of drug escalation","volume":"22","author":"Ahmed","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1124\/jpet.114.219873","article-title":"Effects of \u03bc-opioid receptor agonists in assays of acute pain-stimulated and pain-depressed behavior in male rats: role of \u03bc-agonist efficacy and noxious stimulus intensity","volume":"352","author":"Altarifi","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.12.005_bib0015","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0376-8716(03)00097-8","article-title":"Guidelines and methodological reviews concerning drug abuse liability assessment","volume":"70","author":"Balster","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s002130100821","article-title":"Importance of sex and relative efficacy at the \u03bc opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids","volume":"158","author":"Barrett","year":"2001","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.12.005_bib0025","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1124\/jpet.102.047068","article-title":"Use of irreversible antagonists to determine the relative efficacy of \u03bc-opioids in a pigeon drug discrimination procedure: Comparison of \u03b2-funaltrexamine and clocinnamox","volume":"306","author":"Barrett","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.neubiorev.2018.12.005_bib0030","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00004714-200012000-00002","article-title":"Comparative abuse liability of intravenously administered remifentanil and fentanyl","volume":"20","author":"Baylon","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0376-8716(93)90059-Y","article-title":"Behavioral economics: a novel experimental approach to the study of drug dependence","volume":"33","author":"Bickel","year":"1993","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.12.005_bib0040","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/BF02245952","article-title":"The behavioral economics of concurrent drug reinforcers: a review and reanalysis of drug self-administration research","volume":"118","author":"Bickel","year":"1995","journal-title":"Psychopharmacology"},{"issue":"19-20","key":"10.1016\/j.neubiorev.2018.12.005_bib0045","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s00018-005-5277-y","article-title":"Regulation of the extracellular signal-regulated kinases following acute and chronic opioid treatment","volume":"62","author":"Bilecki","year":"2005","journal-title":"Cell. Mol. Life Sci. CMLS"},{"issue":"5449","key":"10.1016\/j.neubiorev.2018.12.005_bib0050","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking \u03b2-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"issue":"6813","key":"10.1016\/j.neubiorev.2018.12.005_bib0055","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/35047086","article-title":"\u03bc-Opioid receptor desensitization by \u03b2-arrestin-2 determines morphine tolerance but not dependence","volume":"408","author":"Bohn","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.12.005_bib0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.1985.03360010087032","article-title":"Toxicity associated with long-term intravenous heroin and cocaine self administration in the rat","volume":"254","author":"Bozarth","year":"1985","journal-title":"J. Am. Med. Assoc."},{"issue":"5","key":"10.1016\/j.neubiorev.2018.12.005_bib0065","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3109\/15563650.2016.1157722","article-title":"Could chest wall rigidity be a factor in rapid death from illicit fentanyl abuse?","volume":"54","author":"Burns","year":"2016","journal-title":"Clin. Toxicol."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.12.005_bib0070","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0024-3205(93)90152-S","article-title":"The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine","volume":"52","author":"Chen","year":"1993","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.neubiorev.2018.12.005_bib0075","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1038\/sj.npp.1301008","article-title":"Unlimited access to heroin self-administration: independent motivational markers of opiate dependence","volume":"31","author":"Chen","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.neubiorev.2018.12.005_bib0080","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpain.2005.05.004","article-title":"Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004","volume":"6","author":"Cicero","year":"2005","journal-title":"J. Pain"},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.drugalcdep.2017.04.004","article-title":"Increases in self-reported fentanyl use among a population entering drug treatment: the need for systematic surveillance of illicitly manufactured opioids","volume":"177","author":"Cicero","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"1-2","key":"10.1016\/j.neubiorev.2018.12.005_bib0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3959(00)00413-9","article-title":"Opiate self administration as a measure of chronic nociceptive pain in arthritic rats","volume":"91","author":"Colpaert","year":"2001","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.12.005_bib0095","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0022-3565(25)10898-7","article-title":"Clocinnamox: a novel, systemically-active, irreversible opioid antagonist","volume":"262","author":"Comer","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.neubiorev.2018.12.005_bib0100","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/sj.npp.1301479","article-title":"Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers","volume":"33","author":"Comer","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"1-3","key":"10.1016\/j.neubiorev.2018.12.005_bib0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.drugalcdep.2009.12.018","article-title":"Abuse liability of oxycodone as a function of pain and drug use history","volume":"109","author":"Comer","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"12","key":"10.1016\/j.neubiorev.2018.12.005_bib0110","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.pain.2012.07.035","article-title":"Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations","volume":"153","author":"Comer","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1124\/jpet.117.246439","article-title":"Application of receptor theory to the design and use of fixed-proportion mu-opioid agonist and antagonist mixtures in rhesus monkeys","volume":"365","author":"Cornelissen","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.12.005_bib0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13643-017-0642-0","article-title":"Risk factors for addiction among patients receiving prescribed opioids: a systematic review protocol","volume":"6","author":"Cragg","year":"2017","journal-title":"Syst. Rev."},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0125","series-title":"Counterfeit Prescription Pills Containing Fentanyl: a Global Threat. DEA Intelligence Brief, DEA-DCT-DIB-021-16, 1-10","author":"Drug Enforcement Administration","year":"2016"},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0130","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/00000542-199505000-00018","article-title":"The effect of intrinsic efficacy on opioid tolerance","volume":"82","author":"Duttaroy","year":"1995","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0135","series-title":"European Drug Report 2017: Trends and Developments","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2017"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.12.005_bib0140","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/ALN.0b013e31820a4edb","article-title":"Opioid facilitation of rewarding electrical brain stimulation is suppressed in rats with neuropathic pain","volume":"114","author":"Ewan","year":"2011","journal-title":"Anesthesiol.: J. Am. Soc. Anesthesiol."},{"issue":"6","key":"10.1016\/j.neubiorev.2018.12.005_bib0145","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/ALN.0b013e3182330448","article-title":"Rewarding Electrical Brain Stimulation in Rats after Peripheral Nerve InjuryDecreased Facilitation by Commonly Abused Prescription Opioids","volume":"115","author":"Ewan","year":"2011","journal-title":"Anesthesiol.: J. Am. Soc. Anesthesiol."},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0150","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugpo.2017.06.005","article-title":"Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic","volume":"46","author":"Fairbairn","year":"2017","journal-title":"Int. J. Drug Policy"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.12.005_bib0155","first-page":"46","article-title":"Clinical investigation of the analgesic potency and respiratory depressant activity of fentanyl, a new narcotic analgesic","volume":"7","author":"Finch","year":"1967","journal-title":"J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.12.005_bib0160","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1526-4637.2007.00370.x","article-title":"What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse\/addiction and\/or aberrant drug-related behaviors? A structured evidence-based review","volume":"9","author":"Fishbain","year":"2008","journal-title":"Pain Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.12.005_bib0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00421185","article-title":"The effect of diazepam and fentanyl on mental, psychomotor and electroencephalographic functions and their rate of recovery","volume":"44","author":"Ghoneim","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0170","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.drugpo.2017.05.052","article-title":"Silicon to syringe: cryptomarkets and disruptive innovation in opioid supply chains","volume":"46","author":"Gilbert","year":"2017","journal-title":"Int. J. Drug Policy"},{"issue":"1-2","key":"10.1016\/j.neubiorev.2018.12.005_bib0175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2007.09.002","article-title":"Behavioral economic analysis of drug preference using multiple choice procedure data","volume":"93","author":"Greenwald","year":"2008","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.12.005_bib0180","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/sj.npp.1300596","article-title":"Mu-opioid self-administration vs passive administration in heroin abusers produces differential EEG activation","volume":"30","author":"Greenwald","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.12.005_bib0185","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0022-3565(25)13068-1","article-title":"Comparative clinical pharmacology of short-acting mu opioids in drug abusers","volume":"277","author":"Greenwald","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.12.005_bib0190","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0376-8716(03)00098-X","article-title":"Principles of initial experimental drug abuse liability assessment in humans","volume":"70","author":"Griffiths","year":"2003","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0195","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/mol.106.028258","article-title":"An opioid agonist that does not induce \u03bc-opioid receptor\u2014arrestin interactions or receptor internalization","volume":"71","author":"Groer","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0200","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2147\/JPR.S131979","article-title":"Factors associated with prescription opioid misuse in a cross-sectional cohort of patients with chronic non-cancer pain","volume":"10","author":"Hah","year":"2017","journal-title":"J. Pain Res."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.12.005_bib0205","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-008-1079-x","article-title":"Controversies in translational research: drug self-administration","volume":"199","author":"Haney","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"issue":"35","key":"10.1016\/j.neubiorev.2018.12.005_bib0210","doi-asserted-by":"crossref","first-page":"12217","DOI":"10.1523\/JNEUROSCI.1053-15.2015","article-title":"Inflammatory pain promotes increased opioid self-administration: role of dysregulated ventral tegmental area \u03bc opioid receptors","volume":"35","author":"Hip\u00f3lito","year":"2015","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.12.005_bib0215","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0306-4530(88)90059-5","article-title":"Influence of the menstrual cycle on neuroendocrine and behavioral responses to an opiate agonist in humans: preliminary results","volume":"13","author":"Hoehe","year":"1988","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.neubiorev.2018.12.005_bib0220","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4530(88)90046-7","article-title":"Human studies on the \u03bc opiate receptor agonist fentanyl: neuroendocrine and behavioral responses","volume":"13","author":"Hoehe","year":"1988","journal-title":"Psychoneuroendocrinology"},{"issue":"12","key":"10.1016\/j.neubiorev.2018.12.005_bib0225","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/j.pain.2013.07.046","article-title":"Addictive behaviors related to opioid use for chronic pain: a population-based study","volume":"154","author":"H\u00f8jsted","year":"2013","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0376-8716(93)90058-X","article-title":"Behavioral economics of drug self-administration: an introduction","volume":"33","author":"Hursh","year":"1993","journal-title":"Drug Alcohol Depend."},{"issue":"5-6","key":"10.1016\/j.neubiorev.2018.12.005_bib0235","first-page":"183","article-title":"Differences in tolerance to anti-hyperalgesic effects between chronic treatment with morphine and fentanyl under a state of pain","volume":"26","author":"Imai","year":"2006","journal-title":"Japan. J. Psychopharmacol."},{"issue":"5-6","key":"10.1016\/j.neubiorev.2018.12.005_bib0240","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/FBP.0b013e3283641c3d","article-title":"A review of human drug self-administration procedures","volume":"24","author":"Jones","year":"2013","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.12.005_bib0245","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/PAF.0b013e31818738b8","article-title":"Deaths with transdermal fentanyl patches","volume":"31","author":"Jumbelic","year":"2010","journal-title":"Am. J. Forensic Med. Pathol."},{"issue":"6","key":"10.1016\/j.neubiorev.2018.12.005_bib0250","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/AJP.0b013e318167a087","article-title":"Internet-based survey of nonmedical prescription opioid use in the United States","volume":"24","author":"Katz","year":"2008","journal-title":"Clin. J. Pain"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0255","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.gene.2011.11.040","article-title":"Association between ABCB1 gene polymorphisms and fentanyl\u2019s adverse effects in Turkish patients undergoing spinal anesthesia","volume":"493","author":"Kesimci","year":"2012","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.12.005_bib0260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0376-8716(02)00107-2","article-title":"Tramadol post-marketing surveillance in health care professionals","volume":"68","author":"Knisely","year":"2002","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.neubiorev.2018.12.005_bib0265","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.cellsig.2015.05.019","article-title":"Mu opioid receptor stimulation activates c-Jun N-terminal kinase 2 by distinct arrestin-dependent and independent mechanisms","volume":"27","author":"Kuhar","year":"2015","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3959(94)00106-O","article-title":"The consumption of fentanyl is increased in rats with nociceptive but not with neuropathic pain","volume":"60","author":"Kupers","year":"1995","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.neubiorev.2018.12.005_bib0275","first-page":"1072","article-title":"Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions","volume":"25","author":"Labroo","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0280","doi-asserted-by":"crossref","first-page":"R1387","DOI":"10.1152\/ajpregu.00530.2005","article-title":"Opiate slowing of feline respiratory rhythm and effects on putative medullary phase-regulating neurons","volume":"290","author":"Lalley","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"15","key":"10.1016\/j.neubiorev.2018.12.005_bib0285","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1111\/j.1742-4658.2008.06531.x","volume":"275","author":"Ligeza","year":"2008","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.12.005_bib0290","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40262-012-0016-7","article-title":"Pharmacokinetics of non intravenous formulations of fentanyl","volume":"52","author":"L\u00f6tsch","year":"2013","journal-title":"Clin. Pharmacokinet."},{"issue":"23","key":"10.1016\/j.neubiorev.2018.12.005_bib0295","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/0024-3205(89)90062-3","article-title":"Morphine self administration in the rat during adjuvant-induced arthritis","volume":"45","author":"Lyness","year":"1989","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.12.005_bib0300","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/2042098617744161","article-title":"Naloxone dosage for opioid reversal: current evidence and clinical implications","volume":"9","author":"Lynn","year":"2018","journal-title":"Ther. Adv. Drug Saf."},{"issue":"45","key":"10.1016\/j.neubiorev.2018.12.005_bib0305","doi-asserted-by":"crossref","first-page":"34515","DOI":"10.1074\/jbc.M604278200","article-title":"Mu opioid receptor activation of ERK1\/2 is GRK3 and arrestin dependent in striatal neurons","volume":"281","author":"Macey","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0310","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-2999(92)90685-W","article-title":"Pharmacological profiles of fentanyl analogs at \u03bc, \u03b4 and \u03ba opiate receptors","volume":"213","author":"Maguire","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0315","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neubiorev.2018.12.005_bib0320","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/BF00541294","article-title":"Simple devices in differentiating the effects of buprenorphine and fentanyl in healthy volunteers","volume":"31","author":"Manner","year":"1987","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0325","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00000542-200702000-00020","article-title":"Opioid Self-administration in the Nerve-injured RatRelevance of Antiallodynic Effects to Drug Consumption and Effects of Intrathecal Analgesics","volume":"106","author":"Martin","year":"2007","journal-title":"Anesthesiol.: J. Am. Soc. Anesthesiol."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.12.005_bib0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000118542","article-title":"Investigations with the specific mu-opiate receptor agonist fentanyl in depressive patients: growth hormone, prolactin, cortisol, noradrenaline and euphoric responses","volume":"21","author":"Matussek","year":"1989","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0335","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/npp.2012.42","article-title":"Evidence that behavioral phenotypes of morphine in beta-arr2-\/- mice are due to the unmasking of JNK signaling","volume":"37","author":"Mittal","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.12.005_bib0340","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1476-5381.2011.01335.x","article-title":"Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human","volume":"164","author":"Morgan","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.12.005_bib0345","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1369-1600.2011.00354.x","article-title":"Possible involvement of prolonging spinal \u03bc\u2010opioid receptor desensitization in the development of antihyperalgesic tolerance to \u03bc\u2010opioids under a neuropathic pain\u2010like state","volume":"18","author":"Narita","year":"2013","journal-title":"Addict. Biol."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0350","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1124\/jpet.105.095380","article-title":"Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone","volume":"317","author":"Negus","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.neubiorev.2018.12.005_bib0355","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/laban.255","article-title":"Expression and treatment of pain-related behavioral depression","volume":"42","author":"Negus","year":"2013","journal-title":"Lab Anim. (NY)"},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0360","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0376-8716(02)00331-9","article-title":"Effects of heroin and its metabolites on schedule-controlled responding and thermal nociception in rhesus monkeys: Sensitivity to antagonism by quadazocine, naltrindole and \u03b2-funaltrexamine","volume":"70","author":"Negus","year":"2003","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.12.005_bib0365","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00000542-199909000-00020","article-title":"Ritonavir\u2019s role in reducing fentanyl clearance and prolonging its half-life","volume":"91","author":"Olkkola","year":"1999","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.12.005_bib0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)10719-2","article-title":"Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperdine or fentanyl in rats","volume":"262","author":"Paronis","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0375","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/BF02244991","article-title":"Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists","volume":"114","author":"Paronis","year":"1994","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.12.005_bib0380","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/FTD.0000000000000465","article-title":"Acute intoxications and fatalities from illicit fentanyl and analogues: an update","volume":"40","author":"Pichini","year":"2018","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0385","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0022-3565(24)37502-0","article-title":"Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys","volume":"285","author":"Pitts","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0390","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1523\/JNEUROSCI.4146-10.2011","article-title":"A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia","volume":"31","author":"Psifogeorgou","year":"2011","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.12.005_bib0395","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuropharm.2010.08.003","article-title":"The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics","volume":"60","author":"Raehal","year":"2011","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.12.005_bib0400","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in \u03b2-arrestin 2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.neubiorev.2018.12.005_bib0405","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1038\/npp.2015.109","article-title":"Receptor reserve moderates mesolimbic responses to opioids in a humanized mouse model of the OPRM1 A118G polymorphism","volume":"40","author":"Robinson","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neubiorev.2018.12.005_bib0410","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1399-6576.1984.tb02013.x","article-title":"Ventilatory and mental effects of Alfentanil and fentanyl","volume":"28","author":"Scamman","year":"1984","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"11","key":"10.1016\/j.neubiorev.2018.12.005_bib0415","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI118699","article-title":"P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs","volume":"97","author":"Schinkel","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.neubiorev.2018.12.005_bib0420","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.cell.2017.10.035","article-title":"Bias factor and therapeutic window correlate to predict safer opioid analgesics","volume":"171","author":"Schmid","year":"2017","journal-title":"Cell"},{"issue":"46","key":"10.1016\/j.neubiorev.2018.12.005_bib0425","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1021\/acs.biochem.6b00948","article-title":"How oliceridine (TRV-130) binds and stabilizes a \u03bc opioid receptor conformational state that selectively triggers G protein signaling pathways","volume":"55","author":"Schneider","year":"2016","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.neubiorev.2018.12.005_bib0430","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/milmed\/149.4.227","article-title":"Fentanyl citrate abuse among health care professionals","volume":"149","author":"Silsby","year":"1984","journal-title":"Mil. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.12.005_bib0435","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s002130050739","article-title":"Tolerance and cross-tolerance to the rate-suppressing effects of opioids in butorphanol-treated rats: influence of maintenance dose and relative efficacy at the mu receptor","volume":"140","author":"Smith","year":"1998","journal-title":"Psychopharmacology"},{"issue":"14","key":"10.1016\/j.neubiorev.2018.12.005_bib0440","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","article-title":"Characteristics of fentanyl overdose \u2013 massachusetts, 2014-2016","volume":"66","author":"Somerville","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"3","key":"10.1016\/j.neubiorev.2018.12.005_bib0445","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/0885-3924(92)90047-L","article-title":"The history and development of the fentanyl series","volume":"7","author":"Stanley","year":"1992","journal-title":"J. Pain Symptom Manage."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0450","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1213\/ane.0b013e3181605add","article-title":"A tribute to Dr. Paul A. J. Janssen: entrepreneur extraordinaire, innovative scientist, and significant contributor to anesthesiology","volume":"106","author":"Stanley","year":"2008","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0455","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/bdd.707","article-title":"Involvement of an influx transporter in the blood-brain barrier transport of naloxone","volume":"31","author":"Suzuki","year":"2010","journal-title":"Biopharm. Drug Dispos."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.12.005_bib0460","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2133\/dmpk.DMPK-11-RG-134","article-title":"Impact of CYP3A5 andABCB1 gene polymorphisms on fentanyl pharmacokinetics and clinical responses in cancer patients undergoing conversion to a transdermal system","volume":"27","author":"Takashina","year":"2012","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.12.005_bib0465","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1208\/s12249-018-0979-2","article-title":"P-glycoprotein restricts ocular penetration of loperamide across the blood-ocular barriers: a comparative study on Mdr1a knock-out and wild type Sprague Dawley rats","volume":"19","author":"Tatke","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0470","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.2042-7158.1974.tb09245.x","article-title":"Contribution of \u2018receptor\u2019affinity to analgesic potency","volume":"26","author":"Terenius","year":"1974","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.12.005_bib0475","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.bjp.0705595","article-title":"G protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal","volume":"141","author":"Terman","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.12.005_bib0480","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0026-895X(25)08634-1","article-title":"Modulation by mu-opioid agonists of guanosine-5\u2019-O-(3-[35S] thio) triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells","volume":"47","author":"Traynor","year":"1995","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0485","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00000542-198702000-00013","article-title":"Epidural and subcutaneous morphine, meperidine (pethidine), fentanyl and sufentanil in the rat: analgesia and other in vivo pharmacologic effects","volume":"66","author":"van den Hoogen","year":"1987","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.neubiorev.2018.12.005_bib0490","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.yrtph.2010.12.007","article-title":"Uniform assessment and ranking of opioid mu receptor binding constants for selected opioid drugs","volume":"59","author":"Volpe","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"11","key":"10.1016\/j.neubiorev.2018.12.005_bib0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079239","article-title":"Effect of chronic pain on fentanyl self-administration in mice","volume":"8","author":"Wade","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0500","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/npp.2014.188","article-title":"Compulsive like responding for opioid analgesics in rats with extended access","volume":"40","author":"Wade","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0505","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s002130000620","article-title":"Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats","volume":"154","author":"Walker","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0510","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1124\/jpet.302.1.101","article-title":"Clocinnamox distinguishes opioid agonists according to relative efficacy in normal and morphine-treated rats trained to discriminate morphine","volume":"302","author":"Walker","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.neubiorev.2018.12.005_bib0515","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00000542-200204000-00019","article-title":"Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein","volume":"96","author":"Wandel","year":"2002","journal-title":"Anesthesiology"},{"issue":"40","key":"10.1016\/j.neubiorev.2018.12.005_bib0520","doi-asserted-by":"crossref","first-page":"10392","DOI":"10.1523\/JNEUROSCI.0603-16.2016","article-title":"T394A mutation at the \u03bc opioid receptor blocks opioid tolerance and increases vulnerability to heroin self-administration in mice","volume":"36","author":"Wang","year":"2016","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.neubiorev.2018.12.005_bib0525","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jama.1983.03340070028021","article-title":"Drug abuse in anesthesia training programs: A survey: 1970 through 1980","volume":"1983;250","author":"Ward","year":"1983","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.neubiorev.2018.12.005_bib0530","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/pr.112.005942","article-title":"Regulation of \u03bc-opioid receptors: desensitization, phosphorylation, internalization, and tolerance","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neubiorev.2018.12.005_bib0535","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0376-8716(00)00166-6","article-title":"The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys","volume":"62","author":"Winger","year":"2001","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0540","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0022-3565(25)24788-7","article-title":"Tolerance to morphine-like stimulus effects of mu opioid agonists","volume":"257","author":"Young","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2-3","key":"10.1016\/j.neubiorev.2018.12.005_bib0545","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF02245155","article-title":"Subjective and behavioral responses to intravenous fentanyl in healthy volunteers","volume":"107","author":"Zacny","year":"1992","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0550","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0899-3289(92)90019-T","article-title":"Effects of fasting on responses to intravenous fentanyl in healthy volunteers","volume":"4","author":"Zacny","year":"1992","journal-title":"J. Subst. Abuse"},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0555","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0091-3057(96)00082-2","article-title":"Midazolam does not influence intravenous fentanyl-induced analgesia in healthy volunteers","volume":"55","author":"Zacny","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.neubiorev.2018.12.005_bib0560","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0376-8716(96)01274-4","article-title":"The effects of a cold-water immersion stressor on the reinforcing and subjective effects of fentanyl in healthy volunteers","volume":"42","author":"Zacny","year":"1996","journal-title":"Drug Alcohol Depend."},{"issue":"12","key":"10.1016\/j.neubiorev.2018.12.005_bib0565","doi-asserted-by":"crossref","first-page":"991","DOI":"10.5414\/CP201987","article-title":"Impact of CYP3A and ABCB1 polymorphisms on the pharmacokinetics and pharmacodynamics of fentanyl","volume":"51","author":"Ziesenitz","year":"2013","journal-title":"Int. J. Clin. Pharmacol. Ther."}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763418302070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763418302070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T09:32:35Z","timestamp":1758965555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763418302070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":113,"alternative-id":["S0149763418302070"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2018.12.005","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2018.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}